Interview with Dr. John R. Thornback, Chief Executive Officer, Dx assays
Nine months ago you were appointed CEO of the company. What brought you to Dx assays? I think Dx Assays is a very interesting opportunity, which is why I came…
Address: Unit #02-01/02/03, Blk 35 Marsiling Ind Estate Road 3, Woodlands Central Industrial Estate, Singapore 739257,Singapore
Tel: +65 6499 0720
Dx assays mission is to provide high-quality molecular assay development and assay validation to their customers with speed and efficiency, coupled with their fee-for-service and co-development business model, Dx assays focus on ‘delivering your success’.
Their laboratories are equipped with the state-of-the-art technologies and are operated by highly qualified personnel according to CE and FDA requirements. They provide fully ISO 9001 and ISO 13485 accredited processes and procedures which gives its clients a guarantee of high quality product development and documentation that meets regulatory requirements
Dx assays provide advanced molecular diagnostic assay development, verification, validation, and high quality product enhancement services. They have a proven track record and have delivered successful projects to a wide variety of pharmaceutical, clinical and diagnostic customers all around the world.
Nine months ago you were appointed CEO of the company. What brought you to Dx assays? I think Dx Assays is a very interesting opportunity, which is why I came…
With healthcare demand rapidly increasing in Asia Pacific and worldwide, the entire healthcare sector is sure to undergo a dramatic revolution. J&J Medical’s Chairman for Asia Pacific discusses his priorities…
As the world’s best airport, Changi Airport is also a fast growing hub for pharma freight shipping, and has demonstrated significant leadership in the world of pharma logistics hubs while…
What role has Southeast Asia played within Evonik’s global business since you became regional president? Peter Meinshausen (PM): Considering Southeast Asia to consist of the ASEAN countries, we have seen…
In an exclusive interview with Brent Scott, President of Asia for Stryker, he highlights the growth potential of the region, Stryker’s aggressive acquisition strategy, and the strategic partnerships in the…
In an exclusive interview with Leslie Chua, the General Manager of the Solutions Division at Hitachi Medical Systems, he elaborates on how the division is building on the synergies of…
DKSH’s VP of Healthcare in Singapore and Malaysia, Dr. Varun Sethi deconstructs the essence of what it means to be a Market Expansion Services provider, while highlighting aspects of the…
The chairman of Singapore’s Medical Technology Industry Group, Albert Lee discusses the association’s key priorities, how they serve to advance the interests of both multinational and local members, and the…
In an exclusive interview, Zuellig Pharma CEO John Davison provides insight into the new Zuellig Health Solutions unit that is providing strategic, topline-focused services in order to support Pharma companies…
Martin Dewhurst of the Global Pharmaceuticals and Medical Products Practice at McKinsey & Company provides his view of the Asia Pacific Medtech Forum 2016 in Singapore and elaborates on the…
Boehringer Ingelheim’s (BI) country managing director in South East Asia and South Korea (SEASK), Gerrard McKenna characterizes the recent changes within the family-owned business as “evolutionary” in nature, while highlighting…
Philips general manager of Health Systems, South East Asia, Johan Vooren highlights the company’s renewed commitment to Singapore with the recent opening of their APAC Center, while detailing the qualities…
Takeda’s President of Emerging Markets Business Unit, Giles Platford, speaks about his assignments across various global markets, his leadership philosophy, as well as the impressive international growth of the company.…
See our Cookie Privacy Policy Here